MLKL and ovarian carcinoma: Zhang et al. [302] found that administration of ceramide nano-liposomes (CNLs) via a nano-scale delivery platform significantly induced selective cell death by promoting MLKL-dependent necroptosis in A2780cp, SKOV3, and PE04 cisplatin-resistance ovarian cancer cells and in ovarian tumor cells of xenografted mice.